Logo image
ONE YEAR SURVIVAL POST TAVR IN PATIENTS WITH NORMAL-FLOW-LOW-GRADIENT VS. PARADOXICAL LOW-FLOW-LOW GRADIENT AORTIC VALVE STENOSIS
Abstract   Peer reviewed

ONE YEAR SURVIVAL POST TAVR IN PATIENTS WITH NORMAL-FLOW-LOW-GRADIENT VS. PARADOXICAL LOW-FLOW-LOW GRADIENT AORTIC VALVE STENOSIS

Mohamad Hemu, Caleb Chiang, Jaafar Alward, Konstantinos Voudris and Hussam Suradi
Journal of the American College of Cardiology, Vol.77(18 Supplement 1), pp.1160-1160
05/11/2021
DOI: 10.1016/S0735-1097(21)02519-5

View Online

Abstract

Background The optimal treatment strategy of symptomatic severe aortic stenosis (SAS) in patients with normal-flow, low gradient SAS (NF-LG-SAS) is currently debatable. We sought to determine whether the prognosis of patients with NF-LG-SAS vs. Paradoxical low-flow-low gradient SAS (LF-LG-SAS) is fundamentally different post transcatheter aortic valve replacement (TAVR) Methods A total of 83 patients (42% female, 85±9.5) who underwent TAVR were retrospectively analyzed. NF-LG-SAS was defined by aortic valve area (AVA) < 1cm2, mean gradient (MG) < 40 mmHg, and indexed stroke volume (SVi) >35 mL/m2. LF-LG-SAS was defined by AVA < 1cm2, MG < 40 mmHg, and SVi < 35 mL/m2. Primary outcome included 1-year all-cause mortality post-TAVR. Heart failure exacerbation, acute coronary syndrome, new onset atrial fibrillation, stroke, and permanent pacemaker placement were included as secondary outcomes Results A total of 29 patients with NF-LG-SAS and 54 with LF-LG-SAS were identified. In multivariate analyses adjusting for covariates of prognostic importance, there was a non-statistically significant trend towards improved survival in patients with NF-LG-SAS vs. LF-LG-SAS (HR 0.28, [95% CI, 0.05-1.38]; P=0.12) (Figure). A separate analysis showed no significant difference between groups with regards to secondary outcomes Conclusion To our knowledge, this is the first study comparing survival after TAVR in patients with paradoxical LF-LG-SAS and NF-LG-SAS.

Details

Metrics

1 Record Views
Logo image